Member Info for roger65

For weeks the buys have out weighed the sells massively but it kept dropping. Looks like the bottom has been hit and perhaps PH are now out for good??

Anyway, what a welcome relief to see some blue for a change. I doubt there will be an RNS as 12% isn't a whopping rise. Good day for once. Been far too few

Blimey, the decision should be obvious but with this mngt team I would not be surprised if they took the much longer De novo route. I had no idea it cd take as long as 2 yrs though. I thought the whole point was to gain access to the US market far more quickly.

GDR needs to generate revenue urgently or it will go bust next year imo. It won’t get another raise through again and I’m sure Peel Hint would not oblige again after the obvious failure to deliver anything since the last one.

Negligible sales in the NHS and outside the UK mean getting MT RNR1 on US shelves is of the utmost importance. If they’d sold something significant to the NHS things would look different but in 2yrs - not even from now but when they decide to submit - the company will spend approx £600k per month. That’s £14.4m in two years, whilst earning about £500k on existing sales and 2x £800k tax refunds. Don’t look very enticing on paper and in all of that time someone cd easily get behind this other machine that is supposedly identical to GDR’s and pip them to the post. As I said the other day, there’s something afoot here and I think Gino and GDR are in real danger of being taken out on the cheap .

Over 2m shares bought today. 336k sold. And....we're flat. Come on Gloria, you gotta admit it looks flipping odd. You think mms are squeaky clean?

P & d crew really tried just then didn't they?! No one trusts this management any longer. They'll throw out an indistinct RNS hoping for a spike and then reward you with another discount to their ii mates of 50%+. I think the next one could be at 0.75p. They haven't done that one yet :)

Hmmmm not one. Bit of a red flag but I guess he's only been here since Jan this year and things are only just turning around. Would be a rather good signal to the market if Guido bought some then....

'Right now, Helium has no revenues or profits. So, it’s a high-risk investment.

This was illustrated recently when the company had to raise £6.4m and issue 590m new shares (at a price of 1.09p) to fund the Blue Star deal. This move sent its share price down significantly, in a big blow to existing investors.

Given the high level of risk here, I’m going to pass on this stock and focus on other exciting opportunities in the market. All things considered, I think there are better growth stocks to buy for my portfolio today.'

I know MF often get it completely wrong but everything they state here is just common sense.

How many shares does the CEO own?

Just reas through that document and it also states (unfortunately for us) that IVD devices take longer because they require more testing data. That's where the US partner - who cannot be named - helping with clinical trials comes into play. So, looking at that I would imagine 152 days is absolutely the quickest review time possible. It will likely take longer. And as stated, we just have not been told when the process will get underway.

The RNS from July 15th states MT-RNR1 'received Breakthrough Device Designation from the U.S. Food and Drug Administration' but it doesn't say when the De novo process is due to begin.

Cheek stated 'Together with our in-place partnership with a multi-state physician led clinical partner with neonatal services expertise covering the majority of U.S. states we look forward to affordable, collaborative and timely progress through the FDA De novo process". So, again, he doesn't say when the process will begin. The sooner the better in my humble opinion. I'll have a read through the transcript from the recent presentation and post info here if I can find something useful on this.

Actually, thinking more on this, if Gino and the BODs know there are going to be no NHS sales contracts landing anytime soon then I hope they have completely focussed on the FDA application and are trying to move that forward in anyway possible. That would make more sense to me as they currently have enough in the kitty to pay for it and could bring FDA approval forwards into early 2025. THAT imo would be a far better use of time in the short term rather than wasting time, money and effort on attempting to get a few single NHS Trusts on board. Sack the sales team and go all out for FDA approval. Throw everything at it. Success on that will change the company's fortunes significantly. Would be great if an RNS landed stating that's what they're doing right now. sp would sail past Gilham's 3.1p in a heart beat.

No sadly not Muminr. I believe in the recent presentation the Company said the submission will get underway early 2025 - this is when monthly spend will increase to £600k to cover the cost of the FDA application - so my expectation is FDA approval will arrive Easter 2025 at the earliest.

Agree with mrgeeebeee I'm afraid. I don't think there are going to be any sales outside Manchester within the NHS. Or indeed any sales abroad, in spite of how many distributors are in place. They doesn't guarantee sales. As such there is going to be a long wait for anything positive and I foresee the sp falling to the placing price if not well below and then another fund raise at god only knows what discount. Big spike once FDA news lands but by then the sp could be well below .5p and a surge or TO bid could be to less than where the sp sits now. Just my view. Budd, Gilham, Cheek, Gino and Russ have all blown this by not finding the right person to get orders placed within the NHS. Cheek was brought on board specifically to do that and he failed, hence his frustrated X post. That's why he's gone imv

Going to be a painful few months. I've set myself another 4 weeks to wait and suffer just on the off chance something lands out of the blue. GLA

Tks. Makes sense.

Marc135 'Patience is needed'

A miracle is needed.

Since July 16th when the company released an RNS stating 'the Company has signed a Memorandum of Understanding ("MOU") with SCHURTER AG ("SCHURTER") to work closely together on technology development and co-branded supercapacitor products', the share price nit .41p but has now dropped by over 40%. This seems like an extremely odd reaction in the share price on what can only be deemed positive news. Thoughts anyone? Are people expecting a fund raise? Is that why volume has dropped off a cliff?

Delivered by * Lorna

So how much will they go for this time and at what discount? We have been told it's coming by Laura as they will run out of cash after the EWT is done - and it's nearly complete.

Any guesses? I'll go first £6m at 0.5p by the end of September. And then another placing before Christmas delivered by Loran in her Santa outfit.

Agreed on your first paragraph but not the second. How can you say mcap of £15m is too low for a company making huge losses? It has just had a truly awful year owing to management failures and political events outside its control. Basically it was just run terribly and lucky to survive the challenges it faced in 2023. The new CEO talks a good game but he needs to deliver results and also hope that events outside the company settle down and go his way too.

And what of the ME family who are lending credit? Hmmm perhaps they will be the first to see significants shoots of recovery and make a move to take over completely? Interesting times for sure and a low level entry point on offer for the next few weeks/months.

Great day for what?

When is the next placing due? What discount this time round? 0.5p?

'shareholders will be given due consideration.'

Well they have considered pis and decided they don't like us it seems. We're going to raise again at another whopping discount. There, we gave you due consideration, and considered we don't need to be bothered by how this will affect any of you. Ta da!

another raise coming soon here once they've announced that Itumbula isn't commercial. What a huge 'ock up. They desperately needed something else to divert attention from Tanz and so diluted existing share holders in order to keep the gravy boat going. Next raise at 0.75? Don't think they've tried that one yet.